Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica M Mita

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|July 15, 2014
Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cellsJun Gong, Monica M Mita
British Journal of Cancer|September 29, 2020
Bromodomain inhibitors a decade later: a promise unfulfilled?Monica M Mita, Alain C Mita
Current Oncology Reports|June 26, 2007
The role of mTOR inhibitors for treatment of sarcomasMonica M Mita, Anthony W Tolcher
Clinical Breast Cancer|July 17, 2003
Mammalian target of rapamycin: a new molecular target for breast cancerMonica M Mita, Alain Mita, Eric K Rowinsky
Expert Review of Clinical Pharmacology|August 27, 2013
Ridaforolimus in advanced or metastatic soft tissue and bone sarcomasMonica M Mita, Jun Gong, Sant P Chawla
Cancer Biology & Therapy|September 26, 2003
The molecular target of rapamycin (mTOR) as a therapeutic target against cancerMonica M Mita, Alain Mita, Eric K Rowinsky
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
Cabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancer?Alain C Mita, Robert Figlin, Monica M Mita
Clinical Colorectal Cancer|August 3, 2004
Development of rationally designed, target-based agents for the treatment of advanced colorectal cancerAlain C Mita, Monica M Mita, Eric K Rowinsky
World Journal of Methodology|March 29, 2016
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityJun Gong, Esha Sachdev, Alain C Mita, et al.
Expert Opinion on Investigational Drugs|January 16, 2013
Vascular-disrupting agents in oncologyMonica M Mita, Liza Sargsyan, Alain C Mita, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|July 15, 2014
Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cellsJun Gong, Monica M Mita
British Journal of Cancer|September 29, 2020
Bromodomain inhibitors a decade later: a promise unfulfilled?Monica M Mita, Alain C Mita
Current Oncology Reports|June 26, 2007
The role of mTOR inhibitors for treatment of sarcomasMonica M Mita, Anthony W Tolcher
Clinical Breast Cancer|July 17, 2003
Mammalian target of rapamycin: a new molecular target for breast cancerMonica M Mita, Alain Mita, Eric K Rowinsky
Expert Review of Clinical Pharmacology|August 27, 2013
Ridaforolimus in advanced or metastatic soft tissue and bone sarcomasMonica M Mita, Jun Gong, Sant P Chawla
Cancer Biology & Therapy|September 26, 2003
The molecular target of rapamycin (mTOR) as a therapeutic target against cancerMonica M Mita, Alain Mita, Eric K Rowinsky
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
Cabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancer?Alain C Mita, Robert Figlin, Monica M Mita
Clinical Colorectal Cancer|August 3, 2004
Development of rationally designed, target-based agents for the treatment of advanced colorectal cancerAlain C Mita, Monica M Mita, Eric K Rowinsky
World Journal of Methodology|March 29, 2016
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityJun Gong, Esha Sachdev, Alain C Mita, et al.
Expert Opinion on Investigational Drugs|January 16, 2013
Vascular-disrupting agents in oncologyMonica M Mita, Liza Sargsyan, Alain C Mita, et al.
Pageof 5